Angiotensin II receptor I blockade prevents stenosis of tissue engineered vascular grafts.
Ruiz-Rosado JD, Lee YU, Mahler N, Yi T, Robledo-Avila F, Martinez-Saucedo D, Lee AY, Shoji T, Heuer E, Yates AR, Pober JS, Shinoka T, Partida-Sanchez S, Breuer CK.
Ruiz-Rosado JD, et al. Among authors: mahler n.
FASEB J. 2018 Jun 15;32(12):fj201800458. doi: 10.1096/fj.201800458. Online ahead of print.
FASEB J. 2018.
PMID: 29906242
Free PMC article.
Our results provide support for pharmacologic treatment with losartan as a strategy to modulate monocyte infiltration into the grafts and thus prevent TEVG stenosis.-Ruiz-Rosado, J. D. D., Lee, Y.-U., Mahler, N., Yi, T., Robledo-Avila, F., Martinez-Saucedo, D., Lee, …
Our results provide support for pharmacologic treatment with losartan as a strategy to modulate monocyte infiltration into the grafts and th …